NCI Contract Number HHSN261201200092C RE: rHDL nanoparticles; AG-13-1008

StatusFinished
Effective start/end date1/11/1219/06/13

Funding

  • LipoMedics, Ltd. Co.: $61,900.00

Keywords

  • Biotechnology & Drug Development, Cancer Research, Nanotechnology